Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Prostate cancer
Topics
Prostate cancer
Publications
Real-world evidence
Treatment patterns
Drug discovery
Genitourinary cancer
Health equity
Methodology
Metastatic breast cancer
Colorectal cancer
Non-small cell lung cancer
Comparative effectiveness
Content type
Publication summary
Case study
Video
Webinar
Clear
Apply filter
Showing 9 of
0
results
Real-world insights into prostate cancer management using EHR-derived data from the UK
ISPOR Europe
Publication summary
Publications
Prostate cancer
Real-world patient characteristics, treatment patterns, and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC): insights by PTEN status
ASCO Annual Meeting
Publication summary
Publications
Treatment patterns
Prostate cancer
Assessment of racial/ethnic inequities in uptake of PSMA-PET scans among patients with metastatic prostate cancer in the United States
ASCO Annual Meeting
Health equity
Prostate cancer
Genitourinary cancer research is incredibly promising, and real-world evidence is a key part of it
Real-world evidence
Case study
Prostate cancer
Genitourinary cancer
Genitourinary cancer insights: Leveraging RWE to learn from the experience of every patient
Real-world evidence
Video
Prostate cancer
Webinar
Genitourinary cancer
Real-world treatment patterns in patients diagnosed with metastatic castration-resistant prostate cancer in the US, 2018-2023
ASCO GU
Publication summary
Publications
Prostate cancer
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study
Annals of Oncology
Real-world evidence
Publication summary
Publications
Methodology
Metastatic breast cancer
Colorectal cancer
Non-small cell lung cancer
Prostate cancer
Plasma circulating tumor DNA (ctDNA) fraction and real-world overall survival (rwOS) in metastatic castration resistant prostate cancer (mCRPC)
ASCO Annual Meeting
Publications
Drug discovery
Prostate cancer
Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer
ASCO Annual Meeting
Publications
Drug discovery
Prostate cancer
View more